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Swinburne University of Technology,
Hawthorn, Victoria, AustraliaThe analysis of the quaternary state of
proteins continues to be of importance
in biophysics (1). Oligomerization is
a key biological control mechanism
in the functioning of proteins at the
cell membrane and throughout the
cellular milieu. For example, receptors
involved in cell signaling appear
to trigger cellular responses after
dimerization or oligomerization from
external cues (i.e., after ligand bind-
ing) (2). Likewise, an increasing
number of diseases have been found
to be related to inappropriate aggrega-
tion or oligomerization leading to path-
ological states (3).
Measurement of the oligomeric state
of proteins in solution has enjoyed
a rich, long history that predates
measurements of oligomerization in
cells. In solution measurements (e.g.,
via size-exclusion chromatography,
analytical centrifugation, light scat-
tering, nuclear magnetic resonance,
mass spectrometry, or fluorescence
anisotropy) the experimentalist has
the luxury of a purified protein of
known concentration, a solvent of
defined composition (buffer, pH, gel,
solid-phase), the ability to perform
measurements under variable con-
ditions (concentration, temperature,
native or denaturing, electric field,
centrifugal field), and at a high
signal/noise (under volume and/or
time integration). Generally speaking,
these classical techniques measurehttp://dx.doi.org/10.1016/j.bpj.2015.07.010
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weight in the micromolar to millimolar
concentration range of solute.
With the advent of brighter fluoro-
phores, improvements in detectors, and
confocal/two-photon microscopy, fluo-
rescence approaches such as single-
molecule fluorescence and fluorescence
correlation spectroscopy enabled mea-
surement of smaller concentrations in
the picomolar to nanomolar range. In
single-molecule spectroscopymeasure-
ments, fluorescent tags are bleached
through a tight focus. The number
of detected bleaching steps yields the
apparent oligomeric state. In fluores-
cence correlation spectroscopy, one
analyzes the photon stream emanating
from molecules as they diffuse through
a small focused confocal volume (4).
Analysis of the temporal autocorrela-
tion function yields the concentration
of species from the zero-time-lag
amplitude and the transport properties
(and therefore apparent molecular
weight) from the shape of the autocorre-
lation function as a function of time.
Alternatively, brightness analysis of
the fluorescence intensity trace can
be performed through fluorescence in-
tensity distribution analysis (FIDA)
(5), photon count histogram (PCH) (6)
analysis, or N&B (7). In the FIDA
approach, the total photon count over a
small time interval (smaller than the
diffusion time) is measured repeatedly
to obtain a PCH. These FIDA and
PCH approaches are useful because
they allow oligomerization to be mea-
sured for small solute concentrations,
and are largely independent of transport
properties of the solute in solution.
The measurement and analysis of
oligomerization in single cells and
subcellular compartments consists of
several challenges. The first problem
is the cell solvent is not homogenous
and the protein interactions with
other species (proteins, nucleic acids,
carbohydrates, lipids, cytoskeleton,
organelles, vesicles) lead to context-
dependent local concentration and
local oligomeric states. This issue can
be overcome by using an imagingapproach. The second problem is the
relationship between molecular weight
and transport coefficient is generally
not the same in or on the cell as it is
in buffer. This requires a FIDA or
PCH-like approach. The third problem
is the concentration of solute and
fluorescent tag is difficult to precisely
control in cells. Labeling and purifi-
cation of the labeled protein is not
possible inside the cell—instead, pro-
teins are generally substoichiometri-
cally labeled. This problem can be
solved if the oligomeric distribution
and the concentration can be measured
concurrently and the influence of label-
ing can be taken into account.
In this issue of the Biophysical Jour-
nal, Godin et al. (1) overcome these
challenges to ultimately determine the
oligomeric state distribution of human
proteolipid protein in the endoplasmic
reticulum (ER) and plasma membrane
of intact single cells. Using spatial in-
tensity distribution analysis (SpIDA),
the authors impressively revealed the
distribution of monomer, dimer, and
tetramer and the concentration (den-
sity) of the human proteolipid protein
in the plasma membrane and ER
compartments. Significantly, muta-
tions in the protein (known to be
responsible for pathological effects)
led to impaired trafficking, which was
linked to the tetrameric form of the
protein in the ER.
This article not only provides a bio-
physical advance but contains impor-
tant control experiments that serve as
lessons for us all. Even genetically
encoded probes are not produced with
100% labeling efficiency. However,
by using a control protein as done in
this work, the extent of unlabeled pro-
teins can be backcalculated and this
calculation used to arrive at a true olig-
omeric distribution of the unknown
protein. This caveat of mislabeling
also applies to endogenous/labeled
protein systems where a genetically
encoded protein is transfected into an
664 Claytonendogenous protein background. In
this article, the authors overcame this
potential problem with a genetic
knock-down system. Alternatively,
one can use cells that do not express
the endogenous protein of interest.
Finally, the use of computer simula-
tions is important when evaluating
any new biophysical technique.
There are yet unexplored vistas of
SpIDA that one can only speculate
upon. By knowing the oligomeric dis-
tribution and the total concentration
of solute, estimates of in-cell dissocia-
tion constants should be possible, lead-
ing to estimates of the energetics
of protein oligomerization in the cell.
Manipulation of the brightness withBiophysical Journal 109(4) 663–664external agents, i.e., through fluores-
cence quenching, might give additional
insights into accessibility. Whatever
the future, you can put away your
insect repellent this summer, as SpIDA
is here to stay.REFERENCES
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